NAS:CDMO (USA)
Business Description
Avid Bioservices Inc
NAICS : 325412
SIC : 2834
2642 Michelle Drive, Suite 200, Tustin, CA, USA, 92780
Description
Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. The company provides a comprehensive range of process development and high-quality CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries.
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.69 | |||||
Equity-to-Asset | 0.41 | |||||
Debt-to-Equity | 1.05 | |||||
Debt-to-EBITDA | 9.45 | |||||
Interest Coverage | 7.1 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.03 | |||||
Beneish M-Score | 17.81 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 21 | |||||
3-Year FCF Growth Rate | -41.7 | |||||
3-Year Book Growth Rate | 44 | |||||
Future 3-5Y Total Revenue Growth Rate Industry Rank | 22.57 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 47.48 | |||||
9-Day RSI | 51.21 | |||||
14-Day RSI | 53.62 | |||||
6-1 Month Momentum % | -10.59 | |||||
12-1 Month Momentum % | -28.38 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.38 | |||||
Quick Ratio | 2.03 | |||||
Cash Ratio | 1.67 | |||||
Days Inventory | 83.2 | |||||
Days Sales Outstanding | 63.41 | |||||
Days Payable | 39.46 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.3 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 30.64 | |||||
Operating Margin % | 12.89 | |||||
Net Margin % | 106.75 | |||||
ROE % | 157.78 | |||||
ROA % | 40.36 | |||||
ROIC % | 87.82 | |||||
ROC (Joel Greenblatt) % | 16.44 | |||||
ROCE % | 6.05 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 10.28 | |||||
Forward PE Ratio | 61.42 | |||||
PE Ratio without NRI | 10.28 | |||||
Price-to-Owner-Earnings | 16.79 | |||||
PS Ratio | 11 | |||||
PB Ratio | 6.75 | |||||
Price-to-Tangible-Book | 6.75 | |||||
Price-to-Operating-Cash-Flow | 130.41 | |||||
EV-to-EBIT | 83.16 | |||||
EV-to-EBITDA | 63.9 | |||||
EV-to-Revenue | 10.33 | |||||
EV-to-Forward-Revenue | 8.55 | |||||
EV-to-FCF | -26.11 | |||||
Price-to-Median-PS-Value | 1.61 | |||||
Price-to-Graham-Number | 1.76 | |||||
Earnings Yield (Greenblatt) % | 1.21 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Gurus Latest Trades with NAS:CDMO
Executives
EMBED
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 119.597 | ||
EPS (TTM) ($) | 1.85 | ||
Beta | 1.93 | ||
Volatility % | 77.15 | ||
14-Day RSI | 53.62 | ||
14-Day ATR ($) | 1.025025 | ||
20-Day SMA ($) | 19.0325 | ||
12-1 Month Momentum % | -28.38 | ||
52-Week Range ($) | 11.3 - 34.51 | ||
Shares Outstanding (Mil) | 61.83 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Avid Bioservices Inc Filings
Document | Form | Filing Date | ||
---|---|---|---|---|
No Filing Data |